Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context

Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context

Background: Health technology assessment (HTA) is a process evaluating various aspects of healthcare technologies to support evidence-based decisions. Benign prostatic hyperplasia (BPH) is a common condition among aging men, significantly affecting QoL. Traditional treatments like transurethral res...

Full description

Saved in:

Bibliographic Details
Main Authors:	Agostino Fortunato, Eugenio Di Brino, Michele Basile, Debora Antonini, Filippo Rumi
Format:	Article
Language:	English
Published:	AboutScience Srl 2025-07-01
Series:	Global & Regional Health Technology Assessment
Subjects:	Benign prostatic hyperplasia Budget impact model HTA Urolift
Online Access:	https://journals.aboutscience.eu/index.php/grhta/article/view/3401
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of an intestinal microbiota enterotypes in ageing man diagnosed with benign prostatic hyperplasia (BPH)
by: Weronika Ratajczak-Zacharko, et al.
Published: (2025-05-01)

The Impact of MISTs on Australian BPO Surgical Trends
by: David Armany, et al.
Published: (2025-04-01)

Burden of Benign Prostatic Hyperplasia (BPH) in Low- and Middle-Income Countries in Sub-Saharan Africa (SSA)
by: Ayun Cassell, et al.
Published: (2024-10-01)

Benign prostatic hyperplasia and periodontitis
by: YANG Shisong, et al.
Published: (2024-03-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective
by: Ananias C. Diokno, et al.
Published: (2024-12-01)

HTA CORE MODEL
by: R. I. Yagudina, et al.
Published: (2015-03-01)

The Role of Intraprostatic Injection of Epinephrine in Reducing Perioperative Blood Loss during Transurethral Resection of the Prostate (TURP) in Patients with Benign Prostatic Hyperplasia (BPH): A Systematic Review & Meta-Analysis
by: Cecilia Noviyanti Salim, et al.
Published: (2025-05-01)

The Role of Intraprostatic Injection of Epinephrine in Reducing Perioperative Blood Loss during Transurethral Resection of the Prostate (TURP) in Patients with Benign Prostatic Hyperplasia (BPH): A Systematic Review & Meta-Analysis
by: Cecilia Noviyanti Salim, et al.
Published: (2025-05-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)

KEJADIAN BATU SALURAN KEMIH PADA PASIEN BENIGN PROSTATE HYPERPLASIA (BPH) PERIODE JANUARI 2013 – DESEMBER 2015 DI RSUP Dr. KARIADI SEMARANG
by: Riski Novian Indra Saputra, et al.
Published: (2016-11-01)

The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
by: Oriol Solà-Morales, et al.
Published: (2025-01-01)

Meta-analysis of Acupuncture Intervening Benign Prostatic Hyperplasia
by: Xueyuan Yang, et al.
Published: (2025-03-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
by: Taofiq Olayinka Mohammed, et al.
Published: (2024-12-01)

Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2020-06-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia
by: QIAN Xinhang, et al.
Published: (2024-02-01)

Prevalence of benign prostatic hyperplasia and prostrate cancer among suburban residents in Southern Nigeria
by: Ugochukwu Esomonu, et al.
Published: (2024-12-01)

OPTIMIZATION OF TREATMENT AND PROGNOSTIC APPROACHES TO BENIGN PROSTATIC HYPERPLASIA COMPLICATIONS
by: S. M. Pikalov, et al.
Published: (2020-11-01)

Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project
by: Andrea Cocci, et al.
Published: (2024-04-01)

Laser technologies in surgery for benign prostate hyperplasia
by: S. A. Rakhimov, et al.
Published: (2024-03-01)

Possibilities of Therapeutic and Prophylactic Tactics in Management of Benign Prostatic Hyperplasia in Tuberculosis Patients
by: Z. R. Rashidov, et al.
Published: (2021-08-01)

Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia
by: Stanislav N. Volkov, et al.
Published: (2024-01-01)

Negative impact of benign prostatic hyperplasia on fertility in dogs–a mini-review
by: Anna Domosławska-Wyderska, et al.
Published: (2025-05-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

Continuation of Selective Alpha Blocker After Transurethral Resection of the Prostate Is Associated with a Decreased Risk of Hip Fractures in Elderly Patients Diagnosed with Benign Prostate Hyperplasia
by: Wei-Hung Wang, et al.
Published: (2025-04-01)

Prostatic Artery Embolization for Benign Prostatic Hyperplasia—A Primer for Interventional Radiologists
by: Tiago Bilhim, et al.
Published: (2021-07-01)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
by: Cheng-Ling Lee, et al.
Published: (2023-01-01)

Outcomes of Prostatic Artery Embolization for Treating Benign Prostatic Hyperplasia Symptoms: A Prospective Single‐Center Study
by: Sina Delazar, et al.
Published: (2025-03-01)

Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?
by: Sandro Gsteiger, et al.
Published: (2024-11-01)

Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)

Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives
by: Aris Kaltsas, et al.
Published: (2025-02-01)

EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?
by: Volker Schuster
Published: (2024-05-01)

Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome
by: Jon Bjarnason, et al.
Published: (2025-07-01)

Relationship and potential mechanisms between gut microbiota and benign prostatic hyperplasia
by: WANG Congcong, et al.
Published: (2024-05-01)

Identification and Characterization of Differentially Expressed MicroRNAs in Benign Prostatic Hyperplasia
by: Lingmin Song, et al.
Published: (2025-04-01)